Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-742-6 | CAS number: 27939-60-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14-05-2008 to 21-05-2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 26th November, 1997
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Dimethylcyclohex-3-ene-1-carbaldehyde
- EC Number:
- 248-742-6
- EC Name:
- Dimethylcyclohex-3-ene-1-carbaldehyde
- Cas Number:
- 27939-60-2
- Molecular formula:
- C9H14O
- IUPAC Name:
- (1R,6R)-3,6-dimethylcyclohex-3-ene-1-carbaldehyde; (1R,6R)-4,6-dimethylcyclohex-3-ene-1-carbaldehyde
- Test material form:
- liquid
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Jackson Laboratories, Bar Harbor, ME
- Age at study initiation: 9-10 weeks at start of dosing
- Weight at study initiation: 18-23 grams at the outset (Day 1) of the study.
- Housing: Animals were group housed (5 per cage) upon receipt in compliance with National Research Council "Guide for the Care and Use of Laboratory Animals".
- Diet: All animals had access to Harlan Teklad Rodent Chow 7012C ad libitum.
- Water: Tap water was available ad libitum, via water bottles.
- Acclimation period: a minimum of 6 days prior to their first day of dosing.
- Indication of any skin lesions: No
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 - 27
- Humidity (%): 22 - 60
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- other: Diethyl Phathalate Special Odorless (1:3 ETOH/DEP)
- Concentration:
- 1, 2.5, 5, 10 or 25 % (v/v)
- No. of animals per dose:
- 5
- Details on study design:
- JUSTIFICATION DOSE LEVELS
In general, the doses were selected so that the highest concentration maximizes exposure while avoiding systemic toxicity and excessive local irritation. Doses were selected based on known reported uses of the material.
ANIMAL ASSIGNMENT AND TREATMENT
- Animals were assigned to study groups based on body weight and apparent good health. Mice were given identification numbers and identified by tail mark with an indelible marker. Treatment of animals was in accordance with the study protocol and also in accordance with SOP's which adhere to the regulations outlined in the USDA Animal Welfare Act (9 CFR Parts 1, 2 and 3) and the conditions specified in the Guide for the Care and Use of Laboratory Animals (ILAR publication, 1996, National Academy Press).
IN-LIFE OBSERVATIONS AND MEASUREMENTS
- Mortality/ morbidity: Daily on Days 1 to 6
- Clinical Observations: Immediately prior to dose administration and immediately post-dose on Days 1 to 3. Clinical observations were performed once daily on Days 4 to 6. Any build up of test article was recorded.
- Dermal Irritation: Daily for signs of erythema and edema. Irritation was scored and recorded using the Draize scoring system. Scoring was performed prior to dosing on Days 1-3.
- Body weight: Animals were weighed on Days 1 and 6.
TREATMENT PREPARATION AND ADMINISTRATION
- Route: Topically on the dorsal surface of both ears
- Frequency: Once daily for 3 consecutive days (Days 1-3). The timing of dose administration remained consistent (± 2 hours) during the dosing phase.
- Procedure: A volume of 25 µL/ear was applied using a micro pipette.
- On Day 6 the mice were injected i.v. with 20 µCi of ³H-thymidine in 250 µL of sterile saline. Five hours later the mice were euthanized by CO2 asphyxiation and the draining auricular lymph nodes were removed.
- At removal, the number of nodes collected per animal was recorded, and the nodes were examined for size/appearance and the data recorded.
- The lymph nodes from each group were pooled and a single cell suspension was prepared, Cells were washed twice with phosphate buffered saline (PBS) and precipitated with 5% trichloroacetic acid (TCA) overnight at 2-8°C. The pellets were recovered by centrifugation and resuspended in 1 mL of TCA and transferred to a vial containing scintillation fluid. An additional a mL of TCA was used to rinse the tube, and it was also transferred to the scintillation fluid.
- Incorporation of ³H-thymidine was measured in a ß-scintillation counter.
EVALUATION CRITERIA
Increases in 3H-thymidine incorporation relative to the vehicle-treated control were derived for each group and recorded as stimulation indices (SI). The criterion for a positive response was that one or more concentration of a test article elicits a 3-fold or greater increase in isotope incorporation relative to the vehicle control. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The evaluation of the equality of means for body weight data was made by a one-way analysis of variance using the F distribution to assess statistical significance. If statistically significant differences between the means are found, a Dunnett’s test was used to determine the degree of significance from the control means.
Results and discussion
- Positive control results:
- The positive control substance, hexyl cinnamic aldehyde, gave a Stimulation Index of 1.75, 3.97 and 7.48 when tested at a concentration of 5, 15 and 35 % v/v, respectively, in diethyl phthalate/ethanol 3:1.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 2.1
- Remarks on result:
- other: 1% (v/v)
- Parameter:
- SI
- Value:
- 2
- Remarks on result:
- other: 2.5% (v/v)
- Parameter:
- SI
- Value:
- 2.9
- Remarks on result:
- other: 5% (v/v)
- Key result
- Parameter:
- SI
- Value:
- 4.2
- Remarks on result:
- other: 10% (v/v)
- Remarks:
- Although the data indicated a positive response, the EC3 could not be calculated since a normal dose range curve was not achieved.
- Key result
- Parameter:
- SI
- Value:
- 2.7
- Remarks on result:
- other: 25% (v/v)
- Remarks:
- While treatment with the test substance did not yield an SI of 3, this may be inaccurate given the other results at lower concentration. It is, however, impossible to make a definitive assessment since individual DPMs were not obtained.
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
- At termination, the lymph nodes from the mice in the vehicle group and the test article treated animals were normal in size and appearance.
EC3 CALCULATION
- Although the data indicated a positive response (10 % (v/v)), the EC3 could not be calcuIated since a normal dose range curve was not achieved.
CLINICAL OBSERVATIONS
- No erythema or edema was noted in any of the mice in the vehicle group or in those dosed with the test article.
- There were no other findings.
MORTALITY
- There was no mortality and all animals appeared normal throughout the study.
BODY WEIGHTS
- There were no statistically significant differences observed between any of the treatment groups.
Applicant's summary and conclusion
- Interpretation of results:
- other: skin sensitizer 1B
- Remarks:
- in accordance with EU CLP (EC No. 1272/2008 and its updates)
- Conclusions:
- The application of the test substance at 10% (v/v) in ETOH/ DEP (1:3) resulted in an increase in isotope incorporation which was greater than 3-fold. Although the EC3 could not be calcuIated because a normal dose range curve was not achieved, based on the positive results of this study, the test substance is considered to be sensitising to the skin.
- Executive summary:
The skin sensitisation potential of the test substance has been tested using the Local Lymph Node Assay (LLNA) according to OECD TG 429 and GLP. The application of the test substance at concentrations of 1, 2.5, 5, 10 and 25% (v/v) in ETOH/DEP (1:3) resulted in an increase in isotope incorporation which was greater than 3-fold only at the 10% v/v concentration. Based on this result, no EC3 value could be calculated since a normal dose range curve was not achieved, but the NOEC can be derived and it is 5%. Still, based on the results of this study, the test substance is considered to be sensitising to the skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.